Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Naruse, S.
Right arrow Articles by Ueda, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Naruse, S.
Right arrow Articles by Ueda, S.

Stroke, Vol 22, 61-65, Copyright © 1991 by American Heart Association


ARTICLES

Effects of atrial natriuretic peptide on ischemic brain edema in rats evaluated by proton magnetic resonance method

S Naruse, Y Aoki, R Takei, Y Horikawa and S Ueda
Department of Neurosurgery, Kyoto Prefectural University of Medicine, Japan.

We examined the effect of atrial natriuretic peptide on cerebral edema in 96 rats. Forty-four rats were given 30 (n = 11), 120 (n = 26), or 150 (n = 7) micrograms/kg of the peptide intravenously over 24 hours after occlusion of the left middle cerebral artery to induce cerebral ischemia. We then measured the brain water content, the brain sodium and potassium contents, the in vitro proton nuclear magnetic resonance longitudinal (T1) and transverse (T2) relaxation times, and the area of the edematous regions. Compared with saline treatment (n = 39), peptide treatment decreased the brain water content in a dose-dependent manner and decreased the brain sodium content significantly (p less than 0.05). Peptide treatment also suppressed the lengthening of both T1 and T2 in edematous tissue (p less than 0.05 and p less than 0.01, respectively) and reduced the area of the edematous regions observed by magnetic resonance imaging (p less than 0.01). Atrial natriuretic peptide appears to have a pharmacological effect on ischemic brain edema, possibly by suppressing the elevation of water content through regulation of electrolyte transport in the brain.


This article has been cited by other articles:


Home page
HypertensionHome page
K.-F. Lin, J. Chao, and L. Chao
Atrial Natriuretic Peptide Gene Delivery Reduces Stroke-Induced Mortality Rate in Dahl Salt-Sensitive Rats
Hypertension, January 1, 1999; 33(1): 219 - 224.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
I. Loubinoux, A. Volk, J. Borredon, S. Guirimand, B. Tiffon, J. Seylaz, P. Meric, and G. A. Rosenberg
Spreading of Vasogenic Edema and Cytotoxic Edema Assessed by Quantitative Diffusion and T2 Magnetic Resonance Imaging
Stroke, February 1, 1997; 28(2): 419 - 427.
[Abstract] [Full Text]


Home page
StrokeHome page
G. A. Rosenberg and E. Y. Estrada
Atrial Natriuretic Peptide Blocks Hemorrhagic Brain Edema After 4-Hour Delay in Rats
Stroke, May 1, 1995; 26(5): 874 - 877.
[Abstract] [Full Text]